Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Chueca Porcuna

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Biochemistry|April 27, 2010
Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzerManuel Conde-Sánchez, Esther Roldán-Fontana, Natalia Chueca-Porcuna, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
[Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance]Natalia Chueca Porcuna, Marta Alvarez Estévez, Jorge Parra Ruiz, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Cefiderocol Resistance in <i>Pseudomonas aeruginosa</i> ST175: A Case Report with Genomic AnalysisRosario Fernández Fernández, Alberto Badillo Carrasco, Natalia Chueca Porcuna, et al.
Microorganisms|March 28, 2026
Clinical Case Report on the Use of Rezafungin in <i>Pneumocystis jirovecii</i> Pneumonia in a Critically Ill PatientRosario Fernández-Fernández, Roberto García-Martínez, Waldo Sánchez-Yebra Fernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 23, 2013
[Low prevalence of hepatitis B virus primary drug resistance in Southern Spain]Marta Alvarez Estévez, Natalia Chueca-Porcuna, Vicente Guillot-Suay, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|October 8, 2016
A safe an easy method for building consensus HIV sequences from 454 massively parallel sequencing dataJose Ángel Fernández-Caballero Rico, Natalia Chueca Porcuna, Marta Álvarez Estévez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 5, 2015
[Study of human immunodeficiency virus transmission chains in Andalusia: analysis from baseline antiretroviral resistance sequences]Santiago Pérez-Parra, Natalia Chueca-Porcuna, Marta Álvarez-Estevez, et al.
Infectious Diseases Now|January 6, 2026
Evolution of pneumococcal serotypes, vaccination uptake, and prognosis of invasive pneumococcal disease: A 9-year multicentre cohort study in Granada (Andalusia, Spain)Elvira Marín-Caba, Mario Enrique Reinoso-Camino, Natalia Chueca-Porcuna, et al.
Journal of Clinical Microbiology|February 8, 2013
Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliterMarta Álvarez Estévez, Natalia Chueca Porcuna, Vicente Guillot Suay, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 23, 2025
External validation of the HANDOC score in a Spanish cohort-Analysis of blood culture scoring and time to positivityPedro Manuel García-Ceberino, Francisco Anguita-Santos, Jara Llenas-García, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Biochemistry|April 27, 2010
Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzerManuel Conde-Sánchez, Esther Roldán-Fontana, Natalia Chueca-Porcuna, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
[Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance]Natalia Chueca Porcuna, Marta Alvarez Estévez, Jorge Parra Ruiz, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Cefiderocol Resistance in <i>Pseudomonas aeruginosa</i> ST175: A Case Report with Genomic AnalysisRosario Fernández Fernández, Alberto Badillo Carrasco, Natalia Chueca Porcuna, et al.
Microorganisms|March 28, 2026
Clinical Case Report on the Use of Rezafungin in <i>Pneumocystis jirovecii</i> Pneumonia in a Critically Ill PatientRosario Fernández-Fernández, Roberto García-Martínez, Waldo Sánchez-Yebra Fernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 23, 2013
[Low prevalence of hepatitis B virus primary drug resistance in Southern Spain]Marta Alvarez Estévez, Natalia Chueca-Porcuna, Vicente Guillot-Suay, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|October 8, 2016
A safe an easy method for building consensus HIV sequences from 454 massively parallel sequencing dataJose Ángel Fernández-Caballero Rico, Natalia Chueca Porcuna, Marta Álvarez Estévez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 5, 2015
[Study of human immunodeficiency virus transmission chains in Andalusia: analysis from baseline antiretroviral resistance sequences]Santiago Pérez-Parra, Natalia Chueca-Porcuna, Marta Álvarez-Estevez, et al.
Infectious Diseases Now|January 6, 2026
Evolution of pneumococcal serotypes, vaccination uptake, and prognosis of invasive pneumococcal disease: A 9-year multicentre cohort study in Granada (Andalusia, Spain)Elvira Marín-Caba, Mario Enrique Reinoso-Camino, Natalia Chueca-Porcuna, et al.
Journal of Clinical Microbiology|February 8, 2013
Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliterMarta Álvarez Estévez, Natalia Chueca Porcuna, Vicente Guillot Suay, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 23, 2025
External validation of the HANDOC score in a Spanish cohort-Analysis of blood culture scoring and time to positivityPedro Manuel García-Ceberino, Francisco Anguita-Santos, Jara Llenas-García, et al.
Pageof 2